In liver IL6/JAK/STAT3 pathway, the major activator of acute-phase proteins [38] regulates gluconeogenesis [39] and induces growth arrest in HCC through regulation of cyclin-dependant kinases and CDKN1A gene expression [40]. The gene discussed is IL6; the disease is hepatocellular carcinoma.